‘I was diagnosed with deadly condition after taking weight-loss jab Mounjaro

A woman says that she was diagnosed with potentially fatal pancreatitis less than two months after starting to gain weight Mounjaro.

Julie Bishop55 years old, decided to buy the online medication as part of a subscription of £ 120 per month after having exhausted other avenues to lose weight.

Mounjaro, the brand name for shooting, has become more and more popular in the United Kingdom since its sales license, and this week has become available On the NHS via a GP.

But despite the loss of the two and a half year stone by taking the weekly jab for eight weeks, Ms. Bishop had to stop after receiving a diagnosis of acute pancreatitis. The condition is when the small organ, located behind the stomach, is ignited. This can cause pancreatic infected, causing septicemia and organ failure that can be fatal.

“I suddenly had intense pain around my stomach And when it has become clear that I could not travel, I went to the local meeting center, “said the mental health worker The independent.

“When I arrived, they made an ECG (electrocardiogram) and when I told them that I had taken Mounjaro, they sent me by taxi to the hospital where I was diagnosed with a pancreatitis after a blood test.

“They said I had to stop taking Mounjaro because it could be linked. Everything was very worrying for me because the drug had worked very well.”

After her diagnosis on May 15, Ms. Bishop underwent two other pancreatic “attacks” which led to hospital visits, and she is now waiting to have magnetic resonance imaging (MRI) to understand the extent of Shame for her pancreasand all complications.

Doctors cannot yet be sure that pancreatitis is linked to the taking of Mounjaro. Another possible cause could be high levels of cholesterol In the body, which can form bile calculations by rapid weight loss and can block the pancreatic canal, leading to pancreatitis.

Its history comes as a new report highlights the possible danger linked to the weight loss of medicine GLP-1 and diabetes Jabs, including Mounjaro.

Official figures for Regulatory agency for drugs and health products (MHRA) reveal that some 181 cases of acute and chronic pancreatitis would have been linked to Mounjaro because it was authorized, resulting in the death of five people.

The figures come from voluntary medical reports of unfavorable incidents with drugs, and the use of a drug may have been coincident on a condition rather than responsible for this.

However, Ms. Bishop said that more should be done to share the risks linked to taking medication.

She bought Mounjaro from an online retailer called Zava, who, according to her, asked her to send basic photos of her body and answer questions from her medical history before sending medication.

She said that she was concerned about the fact that the company, associated with Asda in the United Kingdom, did not respond to her message alerting them to her diagnosis over a month ago.

“I know many people who take it, so I was not initially anxious to use it,” she said.

“I think it would help if it has been explained to people how much their organs, like the pancreas, is important for the body, and the damage that a side effect can really cause.

“I would be tempted to come back on it, but only through the NHS. I think these drugs should really come to the public only by the NHS, potentially paying it, due to the risks involved. ”

On the Zava website, the three stages of a weight loss consultation to obtain JABs are a “fast and simple” medical questionnaire, the choice of favorite treatment and a doctor’s check.

Under the “rare” long -term side effects listed, it includes pancreatitis for the mounjaro.

From this week, people can also get the drug from a general practitioner if they have a BMI of 40 or more, and one of the four out of five conditions which include type 2 diabetes and high blood pressure. Ozempic and Wegovy weight loss jabs are available on the NHS, but only after a reference to a specialized weight management service.

Earlier this month, the best doctor in the NHS, Professor Sir Stephen Powis, said that weight loss jabs could become the most commonly used drugs, as around 1.5 million people now take them in the United Kingdom.

He praised the deployment From Mounjaro during GP surgeries as part of a fight against obesity, saying that one day, they could become available in pharmacies.

But he also warned that drugs could be harmful if they are prescribed without the right checks and enveloping care.

“They can have side effects, including nausea, dehydration and inflammation of the pancreas, and a worrying number of people continue to access it without appropriate checks via the Internet,” he said.

Zava’s medical director, Dr. Zenon Andreou, said that he could not discuss Ms. Bishop’s case due to patients’ confidentiality. He said: “We take very much, the well-being of our patients very, very seriously and we are proud of the way we treat them.

“We are aware that pancreatitis can be one of the side effects of weight loss drugs. We will not prescribe the medication to anyone with pancreatitis. Regarding patient messages and their trip with us, we respond to all messages that require medical care to provide support from us. “

A spokesperson for Lilly, who produces Mounjaro, said that a patient’s leaflet warned that a fiery pancreas was a rare side effect, which has an impact up to 1 in 100. They added: “We encourage patients to consult their doctor or other health professional concerning the side effects they can live and to ensure that they get real drugs from Lilly.”